Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

T imes are bleak in Toyland. So bleak that Bratz dolls’ flowing locks are at risk. “There is no American factory anywhere ...

Bristol Myers Squibb’s new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of ...

Local drugmakers donated $4 million to President Donald Trump’s inauguration committee earlier this year as the administration contemplates tariffs that could impose major financial strain on the ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the ...

Roche said the investment would go toward high-tech research and development sites and new manufacturing facilities in places ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

The Toy Association’s president and CEO said President Trump’s 145 percent tariffs on China will likely jeopardize the ...

Daniel G. Glaherty, the CEO of a Coppell-based toy company, has a message for President Donald Trump in the wake of his ever-changing tariff agenda.

Are pharmaceutical companies earning too much? Deciding whether pharmaceutical companies earn too much money is complicated. In this issue of JAMA, 2 reports take different approaches to the question.

NEW YORK – Swiss pharmaceutical giant Novartis said it ... part of an effort that will create 1,000 jobs at the company. Spending on US operations over the next five years is expected to be ...